Overall, the balance of the different T cell subsets in favor of lower levels of CD8+ T cells compared to CD4+ T cells, and TIM-3+ NK cells, which can further dampen T cell responses within CRC TME, highlighting an immune tolerant environment to aid tumor progression. The gene discussed is CD4; the disease is colorectal carcinoma.